BPCA Collaborative Efforts and Outreach Activities

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) strives to gain input from experts in academia, the government, and industry through different activities and during various stages in a drug study.

The following list represents ongoing and previous activities sponsored by the Obstetric and Pediatric Pharmacology Branch (OPPB) in support of the Best Pharmaceuticals in Children Act (BPCA). Please feel free to contact OPPB staff if you are interested in learning more about these activities.

Meetings

2008   2007   2006   2005   2004

2008

Hepatic Toxicity Following Treatment for Pediatric Graves’ Disease Meeting
October 28, 2008
6100 Executive Boulevard, Rockville, MD
Meeting Minutes (PDF 1.66 mb)

2008 BPCA Biodefense Meeting
September 8-9, 2008
EPN Conference Center, Rockville, Maryland
Meeting Minutes (PDF 2.62 mb)

BPCA Methylphenidate Genetic Toxicity Meeting
August 29, 2008
6100 Executive Boulevard, Rockville, MD
Meeting Minutes (PDF 851.88 kb)

BPCA EU-US Joint Research Initiative Meeting
July 8–9, 2008
6100 Executive Boulevard, Rockville, MD
Meeting Minutes (PDF 1.54 mb)

2008 BPCA Scientific Prioritization Meeting
June 30–July 1, 2008
Fishers Lane Conference Center, Rockville, Maryland
Meeting Minutes (PDF 1.82 mb) 

Outcome Measures for Clinical Trials with Children with
Fragile X Syndrome
May 8–9, 2008
Hyatt Regency, Bethesda, Maryland
Meeting Minutes (PDF 1.31 mb)

top of page

2007

Adolescent Over-the-Counter (OTC) Drug Product Use:
A Public Workshop
December 6–7, 2007
Natcher Conference Center, National Institutes of Health, Bethesda, Maryland
Meeting Minutes (PDF 77 kb)

Pediatric Asthma Therapeutics Group Meeting
June 19, 2007
Conference Call
Meeting Minutes (PDF 35 kb)

Pediatric Hypertension Treatment Working Group Meeting
May 30, 2007
Conference Call
Meeting Minutes (PDF 38 kb)

top of page

2006

2nd Annual Summer Institute in Maternal-Fetal Pharmacology
July 23-29, 2006
Wyndham Denver Tech Center, Denver, Colorado

Pediatric Hypertension Treatment Working Group Meeting
April 7, 2006
Marriott Bethesda North Hotel and Conference Center, Bethesda, Maryland
Meeting Minutes (PDF 162 kb)

NICHD Global Consortium on Pediatric Pharmacology Meeting
March 6, 2006
Hyatt Regency Baltimore, Baltimore, Maryland
Meeting Minutes (PDF 208 kb)

Emergency Research in Children: Ethical, Regulatory, and Clinical Challenges Workshop
January 12-13, 2006
Bethesda Marriott, Bethesda, Maryland
Meeting Minutes (PDF 188 kb)

top of page

2005

Pediatric Formulation Initiative (PFI) Working Meeting
December 6-7, 2005
Bethesda Marriott, Bethesda, Maryland
Meeting Minutes (PDF 250 kb)

The goal of the Pediatric Formulation Initiative is for researchers and experts in pediatric formulation to meet to discuss issues and challenges that may stimulate further research in the field. The first phase of the PFI is currently under way with the formation of discussion groups. The following four groups have been created:

• Scientific, technical, and regulatory barriers for the development of pediatric formulations
• Taste, smell, and flavor research in infants and children
• Economic issues and partnerships
• Use and application in pediatrics of new drug delivery systems.

Pediatric Hypertension Treatment Working Group Meeting
June 17, 2005
Doubletree Rockville, Rockville, Maryland
Meeting Minutes (PDF 68 kb)

Improving Pediatric Therapeutics Through the Best Pharmaceuticals for Children Act of 2002
May 16, 2005
Grand Hyatt, Washington, DC
Meeting Minutes (PDF 1.71 MB)

top of page

2004

Extrapolation of Non-Clinical Models to Pediatric Clinical Studies: Setting the Research Agenda
October 28, 2004
Neuroscience Center, Rockville, Maryland
Meeting Minutes (PDF 188 kb)

Newborn Drug Development Initiative Meeting
March 29-30, 2004
Baltimore Marriott Waterfront, Baltimore, Maryland
Meeting Minutes (PDF 360 KB)
Meeting Minutes Appendices (PDF 377 kb)

top of page